SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-008860
Filing Date
2021-01-28
Accepted
2021-01-28 17:14:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm214485-1_424b5.htm 424B5 520316
2 GRAPHIC lg_outlook-therapeutics.jpg GRAPHIC 44006
  Complete submission text file 0001104659-21-008860.txt   582155
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-231922 | Film No.: 21566306
SIC: 2836 Biological Products, (No Diagnostic Substances)